Brand-Name, Generic Reglan Makers Beat Injury Suit

Law360, New York (September 28, 2012, 7:51 PM EDT) -- An Ohio federal judge ruled Thursday that neither brand-name nor generic makers of the anti-heartburn medication Reglan can be held liable in a woman's suit linking her neurological disorder to generic Reglan, since brand-name companies did not make the products and claims against the generics companies are preempted by federal law.

U.S. District Judge Michael Watson granted summary judgment motions from brand-name defendants Pfizer Inc., Pfizer unit Wyeth LLC and Schwarz Pharma, now known as UCB Inc., and a motion for judgment on the pleadings from...
To view the full article, register now.




Case Information

Case Title

Hogue et al v. Pfizer, Inc. et al

Case Number



Ohio Southern

Nature of Suit

Personal Inj. Prod. Liability


Michael H. Watson

Date Filed

September 9, 2010

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.